Biological Agents | List of Frontiers open access articles

Review

Published on 02 Oct 2020

A Comprehensive Review of Biological Agents for Lupus: Beyond Single Target

in Autoimmune and Autoinflammatory Disorders

Bingyi Yang
Ming Zhao
Haijing Wu
Qianjin Lu

Frontiers in Immunology

doi 10.3389/fimmu.2020.539797

27,061 views
22 citations

Review

Published on 18 Jan 2024

Anthrax outbreak: exploring its biological agents and public health implications

in Emerging Tropical Diseases

Seto C. Ogunleye
Mercy M. Olorunshola
Kolapo A. Fasina
Abdullahi T. Aborode
Olalekan C. Akinsulie
Abimbola Amoo
Boluwatife J. Olatoye
Akeem Bakare
Mariam A. Lawal
Oluwabori Adekanye

Frontiers in Tropical Diseases

doi 10.3389/fitd.2023.1297896

15,732 views
15 citations

Review

Published on 15 Aug 2023

Biological agents and the aging brain: glial inflammation and neurotoxic signaling

in Aging, Metabolism and Redox Biology

Amanda S. Latham
Julie A. Moreno
Charlize E. Geer

Frontiers in Aging

doi 10.3389/fragi.2023.1244149

6,662 views
22 citations

Original Research

Published on 08 Jan 2025

Effects of biological agents on rhizosphere microecological environment and nutrient availability for rice

in Microbe and Virus Interactions with Plants

Hang Zhou
Kaibo Yu
Lingli Nie
Lang Liu
Jianqun Zhou
Kunlun Wu
Honghong Ye
Zhaohui Wu

Frontiers in Microbiology

doi 10.3389/fmicb.2024.1447527

2,367 views
3 citations

Original Research

Published on 22 Jul 2022

Efficacy of biological agents and fillers seed coating in improving drought stress in anise

in Plant Abiotic Stress

Atefeh Hoseini
Amin Salehi
R. Z. Sayyed
Hamidreza Balouchi
Ali Moradi
Ramin Piri
Bahman Fazeli-Nasab
Peter Poczai
Mohammad Javed Ansari
Sami Al Obaid

Frontiers in Plant Science

doi 10.3389/fpls.2022.955512

7,587 views
27 citations

Original Research

Published on 07 May 2021

Tapering of Biological Agents in Juvenile ERA Patients in Daily Clinical Practice

in Rheumatology

Chun-Hua Liao
Bor-Luen Chiang
Yao-Hsu Yang

Frontiers in Medicine

doi 10.3389/fmed.2021.665170

4,181 views
6 citations

Review

Published on 20 May 2024

Application of biological agents in the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis

in Renal Pharmacology

Weijun Liu
Guanyuan Tian
Chao Chen
Mingying Zhang
Zhanmao Chen
Tietao Chen
Zhibin Lin
Wuzhong Wu
Yiqaing Wu
Kefei Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1378384

4,992 views
2 citations

Mini Review

Published on 22 Jun 2023

Ocular surface complications following biological therapy for cancer

in Clinical Toxicology

Kevin Sheng-Kai Ma
Ping-Feng Tsai
Tina Yi-Jin Hsieh
James Chodosh

Frontiers in Toxicology

doi 10.3389/ftox.2023.1137637

4,527 views
15 citations

Review

Published on 26 Feb 2026

Progress of biological agents and CAR cell therapy in the treatment of common autoimmune diseases in children

in Pediatric Immunology

Qi-Ling Yin
You-Qiong Liu
Hui-Min Zhang
Yu-Dong Gao
Ying Wang
Wei-Hua Zhang

Frontiers in Pediatrics

doi 10.3389/fped.2026.1742663

424 views

Review

Published on 23 Mar 2026

Individualized precision therapy for severe asthma: clinical applications of biological agents and frontiers of cell therapy

in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Guanji Chen
Chunyan Wang
Yi Han
Zhitao Jiang

Frontiers in Immunology

doi 10.3389/fimmu.2026.1775111

624 views

Review

Published on 13 Apr 2022

Adalimumab in Pediatric Inflammatory Bowel Disease

in Pediatric Gastroenterology, Hepatology and Nutrition

So Yoon Choi
Ben Kang

Frontiers in Pediatrics

doi 10.3389/fped.2022.852580

10,135 views
7 citations

Review

Published on 31 May 2017

Biosafety and Biosecurity in European Containment Level 3 Laboratories: Focus on French Recent Progress and Essential Requirements

in Infectious Diseases: Epidemiology and Prevention

Boris Pastorino
Xavier de Lamballerie
Rémi Charrel

Frontiers in Public Health

doi 10.3389/fpubh.2017.00121

49,975 views
35 citations

Original Research

Published on 05 Feb 2026

Comparative safety of denosumab and romosozumab in osteoporosis: an analysis based on the FDA adverse event reporting system database

in Rheumatology

Jian Sun
Ciren Lunzhu
Yao Wu
Jun Li

Frontiers in Medicine

doi 10.3389/fmed.2026.1766601

1,745 views

Original Research

Published on 11 Sep 2019

Adverse Events in Patients With Rheumatoid Arthritis and Psoriatic Arthritis Receiving Long-Term Biological Agents in a Real-Life Setting

in Drugs Outcomes Research and Policies

Mayara Costa de Camargo
Bruna Cipriano Almeida Barros
Izabela Fulone
Marcus Tolentino Silva
Miriam Sanches do Nascimento Silveira
Iara Alves de Camargo
Silvio Barberato-Filho
Fernando de Sá Del Fiol
Luciane Cruz Lopes

Frontiers in Pharmacology

doi 10.3389/fphar.2019.00965

11,192 views
43 citations

Review

Published on 06 Dec 2021

Biologics for Psoriasis During the COVID-19 Pandemic

in Dermatology

Huanhuan Zeng
Siyu Wang
Ling Chen
Zhu Shen

Frontiers in Medicine

doi 10.3389/fmed.2021.759568

28,905 views
15 citations

Original Research

Published on 12 Apr 2022

A Novel Method for Training the Interdiction of Restricted and Hazardous Biological Materials by Detection Dogs

in Infectious Diseases – Surveillance, Prevention and Treatment

Melissa Singletary
Sarah Krichbaum
Thomas Passler
Lucia Lazarowski
Terrence Fischer
Scott Silvis
L. Paul Waggoner
Paul Walz
Craig Angle

Frontiers in Medicine

doi 10.3389/fmed.2022.847620

3,752 views
7 citations

Articles

A Comprehensive Review of Biological Agents for Lupus: Beyond Single Target

Anthrax outbreak: exploring its biological agents and public health implications

Biological agents and the aging brain: glial inflammation and neurotoxic signaling

Effects of biological agents on rhizosphere microecological environment and nutrient availability for rice

Efficacy of biological agents and fillers seed coating in improving drought stress in anise

Tapering of Biological Agents in Juvenile ERA Patients in Daily Clinical Practice

Application of biological agents in the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis

Ocular surface complications following biological therapy for cancer

Progress of biological agents and CAR cell therapy in the treatment of common autoimmune diseases in children

Individualized precision therapy for severe asthma: clinical applications of biological agents and frontiers of cell therapy

Adalimumab in Pediatric Inflammatory Bowel Disease

Biosafety and Biosecurity in European Containment Level 3 Laboratories: Focus on French Recent Progress and Essential Requirements

Comparative safety of denosumab and romosozumab in osteoporosis: an analysis based on the FDA adverse event reporting system database

Adverse Events in Patients With Rheumatoid Arthritis and Psoriatic Arthritis Receiving Long-Term Biological Agents in a Real-Life Setting

Biologics for Psoriasis During the COVID-19 Pandemic

A Novel Method for Training the Interdiction of Restricted and Hazardous Biological Materials by Detection Dogs